AKT1 and cancer: A potential treatment strategy might involve the inhibition of PI3K/Akt pathway which can help reduce tumour growth and sensitise cancer cells to immune attack and administer an immune checkpoint inhibitor concurrently, to recognize and attack cancer cells more effectively.